Charles river leverages advanced technology to expedite oncology drug discovery and development

Wilmington, mass.--(business wire)---- $crl #lifeatcrl--ahead of aacr 2025, charles river announces updates to its comprehensive portfolio to support the discovery and development of novel oncology drugs.

CRL Ratings Summary

CRL Quant Ranking